Website profile

Stockstotrade

Timothy Sykes is a millionaire penny stock trader and entrepreneur. He is best known for earning $1.65 million by day trading while attending Tulane University.

  • 411articles · 30d
  • 1+ day agolatest article
  • Aug 16, 2026earliest in window
  • 88%with images
  • 348avg words
articles per day
Categories
  • Economy, Business & Finance 411
  • Finance & Business 411
  • News 290
  • Finance 106
  • Business & Industrial 11
  • Autos & Vehicles 3
  • Health & Wellness 1

Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News


timothysykes.com > news > postholdingsinc-post-news-2026_08_28-2

Post Holdings Stock Slips As Analysts Trim Price Targets After Mixed Quarter

2+ week, 2+ day ago   (483+ words) Post Holdings Inc. stocks have been trading up by 4.74 percent following upbeat sentiment around its latest strategic growth developments. What Traders Need To Know Q3 adjusted EPS of $1.78 beat roughly $1.70–$1.71 consensus, but $1.95B revenue missed about $2.03B and dipped slightly year over year....


timothysykes.com > news > postholdingsinc-post-news-2026_08_28

Post Holdings Stock Dips As EPS Beat Meets Target Cuts

2+ week, 2+ day ago   (740+ words) Post Holdings Inc. stocks have been trading up by 4.74 percent following strong earnings momentum and optimistic growth outlook. What Traders Need To Know Q3 adjusted EPS of $1.78 beat estimates around $1.70–$1.71, but $1.95B in revenue missed roughly $2.03B expectations, driving a mixed read on…...


timothysykes.com > news > capricor-therapeutics-inc-capr-news-2026_08_24

CAPR Stock Surges As FDA Keeps Duchenne Pathway Alive

3+ week, 1+ hour ago   (353+ words) Capricor Therapeutics Inc. stocks have been trading up by 13.75 percent after promising biotech progress boosted investor optimism. CAPR has traded like a biotech rollercoaster this month. The daily chart shows Capricor Therapeutics pinned near $4 ahead of its Q2 2026 update, then exploding…...